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Abstract
Background: Fucoidan extract (FE), an enzymatically digested compound with a low molecular weight, is extracted from
brown seaweed. As a natural compound with various actions, FE is attractive, especially in Asian countries, for improving the
therapeutic efficacy and safety of cancer treatment. The present study was carried out to investigate the anti-tumor
properties of FE in human carcinoma cells and further examine the underlying mechanisms of its activities.
Methodology/Principal Finding: FE inhibits the growth of MCF-7, MDA-MB-231, HeLa, and HT1080 cells. FE-mediated
apoptosis in MCF-7 cancer cells is accompanied by DNA fragmentation, nuclear condensation, and phosphatidylserine
exposure. FE induces mitochondrial membrane permeabilization (MMP) through loss of mitochondrial membrane potential
(DYm) and regulation of the expression of Bcl-2 family members. Release of apoptosis-inducing factor (AIF) and cytochrome
c precedes MMP. AIF release causes DNA fragmentation, the final stage of apoptosis, via a caspase-independent
mitochondrial pathway. Additionally, FE was found to induce phosphorylation of c-Jun N-terminal kinase (JNK), p38, and
extracellular signal-regulated kinase (ERK) 1/2, and apoptosis was found to be attenuated by inhibition of JNK. Furthermore,
FE-mediated apoptosis was found to involve the generation of reactive oxygen species (ROS), which are responsible for the
decrease of DYm and phosphorylation of JNK, p38, and ERK1/2 kinases.
Conclusions/Significance: These data suggest that FE activates a caspase-independent apoptotic pathway in MCF-7 cancer
cells through activation of ROS-mediated MAP kinases and regulation of the Bcl-2 family protein-mediated mitochondrial
pathway. They also provide evidence that FE deserves further investigation as a natural anticancer and cancer preventive
agent.
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Introduction
The polysaccharide known as fucoidan is extracted from marine
brown algae and is known to contain large proportions of L-fucose
and sulfate, along with low amounts of xylose, uronic acid, and
galactose [1–2]. Fucoidan has been reported to possess antioxi-
dant, antiviral, antibacterial, anti-inflammatory, and anticoagulant
activities [1–3]. There is accumulating evidence to support the
proposal that the use of fucoidan as a supplement provides
protection against various cancers. Clinical trials of patients with
breast, cervical, renal, and hepatic carcinomas showed a
significant improvement in tumor regression among patients
who received an alternative medicine treatment regimen based
mainly on fucoidan administration [4]. In vivo studies performed
using mouse xenograft models have demonstrated that FE
suppresses tumor growth of A20-derived lymphoma [5], inhibits
metastasis of Lewis lung adenocarcinoma [6] and 13762 MAT rat
mammary adenocarcinoma [7], and has anti-angiogenesis activity
against Lewis lung adenocarcinoma and B16 melanoma [8]. In
vitro, several mechanisms have been postulated to underlie the
anticancer activity of fucoidan, including induction of apoptosis in
cells derived from human lymphoma, promyelocytic leukemia,
colon carcinoma, breast carcinoma, and hepatoma and prevention
of angiogenesis and invasion in HT1080 fibrosarcoma cells [9–15].
However, the molecular mechanisms involved in the anticancer
action of fucoidan are complex, and the targets and molecular
mechanisms by which it initiates death of cancer cells are
incompletely understood.
Apoptosis is a representative form of programmed cell death,
which has been assumed to be critical for cancer prevention [16].
Apoptotic cell death is characterized by the activation of either the
extrinsic pathway, which is initiated by activation of death
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pathway, which is marked by mitochondrial depolarization,
release of cytochrome c, and subsequent activation of caspase-9
[17–19]. Although caspase activation is considered a hallmark of
apoptotic cell death, other apoptogenic proteins that appear not to
require caspase activation have been described. Examples include
apoptosis-inducing factor (AIF), endonuclease G, and smac. AIF is
a mitochondrial protein that mediates caspase-independent
apoptosis in a number of model systems after translocation into
the cytosol or into the nucleus [20–22]. When AIF is released from
the mitochondria in response to apoptotic stimuli, it becomes an
active executioner of the cells by causing condensation of
chromatin in the nuclei and large-scale fragmentation of DNA
[23].
Mitochondria play a central role in the induction and control of
apoptosis. The Bcl-2 family members are key players in the
mitochondria-dependent intrinsic pathway of apoptosis [24]. The
Bcl-2 family consists of pro- and anti-apoptotic proteins that work
together and with other proteins to maintain a dynamic balance
between the survival and death of cells. The mitogen-activated
protein (MAP) kinases, a family of serine/threonine kinases, are
also involved in apoptosis and cell survival and have been
validated as targets for anticancer drugs [25–26]. JNK and p38 are
induced by stress responses and cytokines and can mediate
differentiation and cell death [25,27]. ERK1/2 is generally
associated with cell proliferation and growth [25,27]. Previous
studies have demonstrated that JNK, p38, and ERK 1/2 have
essential roles in modulating the function of the mitochondrial pro-
and anti-apoptotic proteins [28–31]. ROS are the byproducts of
normal cellular oxidative processes and have been suggested to be
involved in regulating the initiation of apoptotic signaling.
Increased levels of ROS have been demonstrated to induce
depolarization of the mitochondrial membrane, which eventually
produces an increase in the level of other pro-apoptotic molecules
in cells [32–33].
On the basis of this knowledge, we determined the growth
inhibition activity of FE in several cancer cell lines and further
investigated the mechanisms of apoptosis triggered by FE in MCF-
7 cancer cells. We have examined activation of members of the
caspase family as well as expression of mitochondrial-dependent
apoptotic factors and ROS-dependent phosphorylation of MAP
kinases in response to FE. Our results indicate that FE induces
apoptosis via a caspase-independent pathway involving mitochon-
drial permeabilization, activation of Bcl-2 family proteins, and
release of cytochrome c and AIF. ROS-dependent JNK phos-
phorylation is an upstream cellular event that is involved in the
mitochondria-dependent apoptotic pathway.
Results
Effect of FE on the growth of cancer cell lines
The effects of FE on several carcinoma cell lines were
examined using the MTT assay. The cells were treated with
different doses of FE for the indicated time periods. As shown in
Figure 1, FE treatment inhibits cell growth of MCF-7 (60%
growth inhibition after FE treatment for 96 h), MDA-MB-231
(41% growth inhibition after FE treatment for 96 h), HeLa (52%
growth inhibition after FE treatment for 96 h), and HT1080
(40% growth inhibition after FE treatment for 96 h) cells. MCF-7
cells were much more sensitive than the other three cell lines to
different doses of FE. The non-malignant MCF-10A cell line
exhibits lower sensitivity to FE treatment than the malignant cell
lines. K562 leukemia, U937 lymphoma, and HL-60 leukemia cell
lines have previously been found to be sensitive to growth
inhibition by FE treatment (data not shown). These data indicate
that FE mediates broad-spectrum growth inhibition of human
carcinoma cells.
FE induces apoptosis in MCF-7 cancer cells
To determine whether FE-induced cytotoxicity involves alter-
ations in cell cycle progression, the DNA content was analyzed by
flow cytometry. Figure 2A shows that FE causes a significant
increase in the percentage of cells in the sub-G1 phase of the cell
cycle in a time-dependent manner. The percentage of cells in the
sub-G1 phase increased almost 6-fold over 96 h in the presence of
820 mg/mL FE relative to the control. However, no significant
changes in cell cycle distribution were observed (Figure 2B).
The induction of apoptosis by FE in MCF-7 cells was confirmed
in fluorescence photomicrographs of cells stained with Hoechst
33342. Figure 2C clearly demonstrates a shrunken nucleus and
peripherally clumped and fragmented chromatin. These charac-
teristics are typical of apoptotic cells. FE treatment also caused
cells to lose their phospholipid membrane asymmetry. The
exposure of phosphatidylserine to the outside of the plasma
membranes was detected by annexin V-FITC staining in MCF-7
cells. The annexin V staining results (Figure 2D and 2E) indicate
that FE causes a significant increase in the number of apoptotic
cells (annexin V positive) in a time-dependent manner. The effect
of L-fucose (1 mg/mL) on MCF-7 cancer cells was not significant
(Figure 2E).
FE mediated apoptosis is caspase-independent
MCF-7 cells are known to not express caspase-3 [34]. To detect
whether other caspases are involved in FE-mediated apoptosis, the
expression of members of the caspase family was analyzed by
western blotting. In our hands, MCF-7 cells treated with FE
showed no significantly increased cleavage of caspase-9 and no
activation of PARP, Bid, caspase-7, or caspase-8 (Figure 3A).
Furthermore, the caspase inhibition assay, which uses a general
caspase inhibitor Z-VAD-fmk as well as inhibitors specific to
caspase-3/7, caspase-8, and caspase-9, was performed with
annexin V/PI double staining analysis. However, as shown in
Figure 3B, all caspase inhibitors failed to attenuate FE-induced
apoptotic cell death. Additionally, Z-VAD-fmk showed no
protective effects on phosphatidylserine exposure induced by FE
(Figure 2E). These results suggest that caspase activation is not
necessary for induction of apoptosis by FE in MCF-7 cells.
FE causes mitochondrial dysfunction and regulation of
expression of Bcl-2 family proteins
Mitochondrial membrane potential regulates mitochondrial
permeability. This plays an important role in triggering apoptotic
pathways [35]. We examined the effect of FE on the DYmb y
rhodamine 123 (Rh123) staining. As shown in Figure 4A, FE
treatment of MCF-7 cells induces dissipation of DYma s
indicated by a decrease in green fluorescence emission. The time
course analysis revealed that significant numbers of cells lose
DYm in FE-treated MCF-7 cells (Figure 4B). Bcl-2 family
proteins have been reported to regulate MMP [36–37]. We
therefore examined the expression of Bcl-2 family proteins in FE-
treated MCF-7 cells in a time-dependent manner. Western
blotting analysis revealed that FE treatment suppresses the
expression of anti-apoptotic proteins such as Bcl-2 and Bcl-xl
and moderately increases the expression levels of pro-apoptotic
proteins such as Bax and Bad (Figure 4C). Furthermore, the ratio
of Bax and Bcl-2 was measured by quantification of the bands. As
shown in Figure 4D, FE treatment induces a time-dependent
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established control (MCF-7/Vec) and Bcl-2 overexpressing
MCF-7 (MCF-7/Bcl-2) cell lines as detailed in Materials and
Methods. MCF-7/Bcl-2 cells expressed significantly higher levels
of Bcl-2 than the control cells (Figure 4E). Moreover, FE-treated
MCF-7/Bcl-2 cells demonstrated consistently lower rates of
apoptosis compared with those of similarly treated MCF-7/Vec
cells. These data indicate that FE treatment led to mitochondrial
dysfunction in MCF-7 cells.
FE induces translocation of mitochondrial apoptotic
factors
Mitochondrial damage occurring as a result of drug-induced
apoptosis is often accompanied by the release of mitochondrial
apoptotic factors into the cytosol [38]. We therefore examined
whether AIF plays a role in FE-induced apoptosis. The results of
western blotting showed that FE treatment induces the release of
AIF from the mitochondria into the cytosol in a time-dependent
manner (Figure 5A). AIF localization was determined by
immunofluorescence using a specific antibody. The mitochondria
and nuclei were labeled with MitoTracker and Hoechst 33342,
respectively. As shown in Figure 5B, the untreated MCF-7 cells
exhibit AIF staining in a punctured pattern, indicating its normal
location in the mitochondria together with normal nuclear
morphology. On the other hand, MCF-7 cells treated with FE
exhibit increased diffuse staining of AIF in the nucleus accompa-
nied by chromatin condensation and nuclear fragmentation.
These characteristics are typically caused by apoptosis. In
addition, cytochrome c, another apoptotic regulatory protein,
was detected by western blotting. The time course analysis showed
Figure 1. Effect of FE on the growth of cancer cell lines. Cell proliferation was analyzed using the MTT assay. Cells were treated with 82, 410, or
820 mg/mL FE or with PBS as the vehicle control for different time periods (n=6). Results represent the means 6 SD from three independent
experiments.
doi:10.1371/journal.pone.0027441.g001
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(Figure 5C).
FE induces the activation of MAP kinases in MCF-7 cancer
cells
The MAPK family is involved in processes that induce cell
death [31,39]. In view of this evidence, the effects of FE on the
phosphorylation of JNK, p38, and ERK1/2 (which correlates
with activation of these proteins) were evaluated. MCF-7 cells
were first treated with FE at a concentration of 820 mg/mL for
different lengths of time, and phosphorylation of JNK, p38, and
ERK1/2 were measured by western blot analysis. As shown in
Figure 6A, the phosphorylation of JNK, p38, and ERK1/2 was
detectable after as little as 30 minutes of FE treatment and
persisted for at least 6 h of treatment. These results indicate that
the JNK, p38, and ERK1/2 pathways were activated in response
to FE in MCF-7 cancer cells. To evaluate whether these kinds of
changes caused by FE are associated with apoptosis, we examined
the effects of specific inhibitors on MCF-7 cancer cells in the
following study. Among the different inhibitors tested (Figure 6B),
we observed a significant decrease in the population of apoptotic
cells in cells treated for 48 h with FE in the presence of the JNK-
Figure 2. FE induces apoptosis in MCF-7 cancer cells. (A and B) Sub-G1 cell population in control and FE-treated (820 mg/mL) MCF-7 cells was
measured by flow cytometry as described in the methods section. The cell distribution was analyzed by flow cytometry analysis software. (C) Hoechst
33342 staining of MCF-7 cells treated with or without 820 mg/mL FE for 96 h. Each experiment shown is representative of 20 random fields observed.
(D) Analysis of apoptotic cells by annexin/PI double staining using the IN Cell Analyzer 1000. MCF-7 cells were treated for different time periods with
or without 820 mg/mL FE. Apoptosis was evaluated by determining the percentage of annexin V-positive cells. (E) Annexin/PI double staining of MCF-
7 cells pretreated with 10 mM Z-VAD-fmk or 2 mM NAC. After a 1-h incubation, cells were exposed to 820 mg/mL FE for the indicated time periods.
Cells grown in a medium containing 1 mg/mL L-fucose without FE served as a sugar control. Each experiment shown is representative of 20 random
fields observed. All of the experiments were performed at least in triplicate. All results were obtained from three independent experiments. A
significant difference between treatment and control groups is indicated by p,0.05(*) or p,0.01(**).
doi:10.1371/journal.pone.0027441.g002
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inhibitor of p38 (SB203580) or an inhibitor of ERK (PD98059)
had little effect. Pretreatment with SP600125 also somewhat
decreased JNK phosphorylation after 6 h of FE treatment
(Figure 6C).
Effect of ROS on FE-induced apoptosis in MCF-7 cancer
cells
We used the fluorescent probe DCFH-DA to measure the
generation of intracellular ROS in FE-treated MCF-7 cells. As
shown in Figure 7A and 7B, when the cells were treated with FE,
DCFH-DA-derived fluorescence was observed to increase by 1.5-
fold after the first 30 min, after which the fluorescence steadily
decreased to less than the level of the control within 6 h.
Moreover, the ROS generation was almost completely inhibited
by pretreatment with the scavenger NAC in a time-dependent
manner (Figure 7A). To determine whether ROS participates in
apoptosis, we tested the effect of NAC on FE-treated MCF-7 cells
and found that NAC pretreatment of cells treated with FE for 48 h
partially inhibited the accumulation of apoptotic cells relative to
cells treated with FE alone (Figure 7C).
Interestingly, the detailed analysis of the time course for ROS
generation showed that the fluorescence started to increase at
15 min, with a peak at 30 min (Figure 7A). The phosphorylation
of JNK, p38, and ERK1/2 was detected at 30 min and was
sustained for at least 6 h (Figure 6A). It was important to
compare this time course with the DYm changes caused by FE in
the MCF-7 cells (Figure 4B). In view of these results, we decided
to study whether the generation of ROS could be coincident with
the phosphorylation of JNK, p38, and ERK1/2 and loss of DYm
in FE-treated MCF-7 cancer cells. As shown in Figure 7D,
pretreatment with 2 mM NAC partially attenuated the phos-
phorylation of JNK, p38, and ERK1/2 after 6 h of FE treatment.
This indicates that ROS are required for phosphorylation of
JNK, p38, and ERK1/2. Furthermore, pretreatment with either
SP600125 or NAC partially inhibited the dissipation of DYm
after 48 h of FE treatment (Figure 7E), indicating that ROS-
dependent JNK phosphorylation is an event that occurs upstream
of mitochondrial membrane permeabilization in FE-treated
MCF-7 cells.
Effect of FE on cellular metabolism
To investigate whether FE regulates cellular metabolism, we
examined cellular ATP levels in MCF-7 cells. As shown in
Figure 8A, we detected a reduction in intracellular ATP levels in
MCF-7 cells after 6 h of FE treatment. An even more substantial
decrease in ATP levels was observed when FE was combined with
glucose-free medium. In contrast, annexin V-FITC staining
revealed that the induction of cell death lagged behind the
reduction of ATP levels (Figure 8B). An obvious increase in
annexin V-FITC staining was observed after 24 h of FE treatment
irrespective of the rate of ATP depletion.
Figure 3. Caspase-independent apoptosis is induced by FE. (A) MCF-7 cells were treated with or without 820 mg/mL FE for different time
periods. Cells treated for 6 h with 5 nM staurosporine (STS) served as a positive control. Cleavage of PARP, Bid, and caspase family members was
detected using western blotting. (B) Effects of caspase inhibitors on apoptosis induced by FE. MCF-7 cells were pretreated with various caspase
inhibitors at 10 mM for 1 h followed by incubation with 820 mg/mL FE for 48 h. The apoptotic cells were evaluated by annexin/PI double staining
using the IN Cell Analyzer 1000. All results were obtained from 3 independent experiments.
doi:10.1371/journal.pone.0027441.g003
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Fucoidan is a potent inducer of apoptosis in various cancer cell
lines. However, the molecular mechanism by which fucoidan
initiates apoptosis has not been well characterized. Several studies
have shown that fucoidan induces extrinsic or intrinsic apoptotic
signaling in different cancer cell types via alteration of expression
or activities of mitochondria-associated proteins, cell cycle
regulatory proteins, proteases, and transcription factors [9–15].
It has been reported that at a concentration of 1 mg/mL, fucoidan
induced apoptosis in MCF-7 cells via a caspase-8 dependent
pathway [13] and exhibited antitumor activity toward Huh7 cells
Figure 4. FE induces loss of DYm and regulation of Bcl-2 family proteins expression. (A and B) MCF-7 cells were treated with or without
820 mg/mL FE for the indicated time periods. Disruption of DYm was observed by Rh123/PI double staining and analyzed by the IN Cell Analyzer
1000. The percentage of cells retaining Rh123 in each treatment group was compared with the untreated control. (C) MCF-7 cells were treated with or
without 820 mg/mL FE for different time periods. Bcl-2, Bcl-xl, Bax, and Bad were determined by western blotting using specific antibodies. (D) A
densitometric analysis was used to quantify the levels of Bax and Bcl-2 to evaluate the effect of FE on the Bax/Bcl-2 ratio. (E) Bcl-2 levels in MCF-7/Vec
and MCF-7/Bcl-2 cells were detected by Western blotting. MCF-7/Vec and MCF-7/Bcl-2 cells were treated with or without 820 mg/mL FE for 48 h and
analyzed by Annexin V/PI assay. All of the experiments were performed at least in triplicate. All results were obtained from three independent
experiments. A significant difference between treatment and control groups is indicated by p,0.05(*) or p,0.01(**).
doi:10.1371/journal.pone.0027441.g004
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fucoidan has been found to cause cell death through inactivation
of the NF-kB and AP-1 pathways in human T-cell leukemia virus
type1-infected T cells [10]. In vivo, 150 mg/kg (body weight)
fucoidan inhibited the growth of tumors of a human T-cell
leukemia virus type1-infected T cell line transplanted subcutane-
ously in severe combined immune deficient mice [10]. As these
studies were based on high doses of fucoidan, the dose of fucoidan
associated with pharmacologic exposure and antitumor effects in
vivo requires further study. In this study, we noted that FE at doses
between 82 mg/mL and 820 mg/mL inhibits the growth of MCF-
7, MDA-MB-231, HeLa, and HT1080 cells, but is less toxic
towards the human mammary epithelial cell line MCF-10A. Cell
cycle distribution analysis, nuclear staining, and annexin V-PI
staining were used to monitor FE-induced apoptotic cell death in
MCF-7 cells. L-fucose at 1 mg/mL did not demonstrate any
significant effect on MCF-7 cells by annexin V/PI assay.
Moreover, we found that FE does not affect cell cycle progression.
This precludes the possibility that FE-dependent cytotoxicity in
MCF-7 cells is due to cell cycle arrest.
To study the mechanisms by which FE treatment induces
apoptosis in MCF-7 cells, we examined a number of markers that
are associated with apoptotic cell death. Previous studies have
shown that caspases act as key executors of fucoidan-induced
apoptosis [8–15]. Although FE treatment causes activation of
caspase-9, specific inhibitors failed to attenuate FE-induced
apoptotic cell death in MCF-7 cells. These results have led us to
propose a model in which FE induces caspase-independent
apoptosis in MCF-7 cancer cells.
Mitochondria have been shown to play a central role in the
apoptotic process. Both the extrinsic pathway and the intrinsic
pathway can converge at the mitochondrial level and trigger
mitochondrial membrane permeabilization [35,40–41]. In our
study, depletion of DYm in MCF-7 cancer cells was detected
after treatment with FE for 6 h (Figure 4B). This is consistent
with the hypothesis that mitochondrial dysfunction is an early
event during the process of apoptosis [35]. Any imbalance of the
expression levels of anti- and pro-apoptotic Bcl-2 family proteins
will disrupt the integrity of the outer mitochondrial membrane
[36–37]. We observed that FE up-regulates the expression of pro-
Figure 5. Translocation of mitochondrial apoptotic factors is induced by FE. (A) Time-dependent release of AIF from mitochondria into the
cytosol was measured by western blotting analysis. (B) FE induces translocation of AIF from the mitochondria to the nucleus. MCF-7 cells were treated
with 820 mg/mL FE for 96 h. After incubation with 100 nM MitoTracker Red (red fluorescence), the cells were fixed and permeabilized followed by
immunostaining with an antibody specific for AIF (green fluorescence) and counterstaining with Hoechst 33342 (blue fluorescence) to visualize
nuclear morphology. (C) Time-dependent release of cytochrome c from mitochondria into the cytosol was measured by western blotting analysis.
Similar results were obtained from 3 independent experiments. Each image shown is representative of 20 random fields observed.
doi:10.1371/journal.pone.0027441.g005
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expression of anti-apoptotic proteins Bcl-2 and Bcl-xl. The
Bax/Bcl-2 ratio, which helps to determine the susceptibility of
cells to a death signal by regulating the function of mitochondria
[37], was found to increase in a time-dependent manner.
Importantly, Bcl-2 overexpression partially protected MCF-7
cells against FE toxicity, which further indicates the involvement
of mitochondria in FE-regulated cell death. Membrane depolar-
ization (loss of DYm) induces mitochondrial permeability
transition pore (PTP) formation [42]. It is known that cytochrome
c is released, along with AIF and Smac/Diablo, from the inter-
membrane space of mitochondria into the cytosol through the
mitochondrial PTP [38,42]. The data presented in the present
study indicate that FE treatment induces the migration of
cytochrome c from the mitochondria to the cytosol. We also
found that AIF is translocated from the mitochondria to the
nucleus, where it causes chromatin condensation and large-scale
DNA fragmentation. Interestingly, AIF has been shown to be a
critical mediator of a caspase 3-independent apoptosis pathway in
several cell lines [20,22]. Further genetic targeting experiments
will be required to determine if AIF is required and is sufficient to
promote FE-induced apoptosis. Collectively, these observations
indicate an intriguing role for FE in provoking mitochondrial
damage and regulating apoptotic proteins at or in mitochondria
in MCF-7 cells. Thus, increased mitochondrial depolarization,
regulation of Bcl-2 proteins, and release of cytochrome c and AIF
appear to be major steps leading to the induction of apoptosis in
FE-treated MCF-7 cells.
It has been reported that MAP kinases are involved in
activation of fucoidan-induced apoptosis [8,11]. We demonstrat-
ed that phosphorylation of JNK, p38, and ERK1/2 occurred
rapidly within 30 min after FE exposure in MCF-7 cancer cells.
p38 kinase has been demonstrated to be an essential regulator of
sustained G2 arrest [30,43]. However, we found that FE does
not affect cell cycle progression and that the inhibition of p38
failed to block apoptosis, suggesting that the involvement of p38
is not critical for FE-induced cell death. Fucoidan has been
found to induce MEKK1-dependent and Raf-independent
activation of MEK1/2-ERK1/2 in leukemic cells, and this
activation in turn affects the activation of JNK [44]. Although
our results showed that FE induced phosphorylation of ERK 1/2
i nM C F - 7c e l l s ,i n h i b i t i o no fE R K1 / 2a l s of a i l e dt ob l o c k
apoptosis. This difference in the effect of FE on ERK 1/2 may
be due to cell type-specific factors or to the diversity of fucoidan
structures and their subsequent signaling transduction pathways.
A previous study demonstrated that the duration and intensity of
JNK activation are associated with cell death [45]. We
demonstrated that JNK phosphorylation occurred rapidly,
within 30 min of FE treatment, and persisted for at least 6 h
after FE exposure; we also observed increased levels of both
phosphor-JNK1 and phosphor-JNK 2 isoforms. Apoptotic cell
death is significantly promoted in cells expressing JNK but
effectively suppressed in cells expressing a dominant-negative
(dn) JNK 1 mutant [46]. Moreover, dnJNK1 has been reported
to block the anti-IgM-induced DYm in B cells [47]. In our study,
JNK1 phosphorylation was efficiently inhibited by SP600125, a
Figure 6. Roles of MAPKs in FE-induced apoptosis. (A) MCF-7 cells were treated with 820 mg/mL FE for the indicated time periods. JNK, p38,
and ERK1/2 MAPKs and their phosphorylated forms were determined by western blotting using specific antibodies. (B) Effects of MAPK inhibitors on
apoptosis induced by FE. MCF-7 cells were pretreated with 10 mM SP600125, SB203580, or PD98059 for 1 h and then exposed to 820 mg/mL FE for
48 h (controls were not exposed to FE). After the treatment, annexin V-PI double staining was used to analyze apoptotic cell death using the IN Cell
Analyzer 1000. All results were obtained from 3 independent experiments. Differences with p,0.05(*) or p,0.01(**) are considered statistically
significant. (C) Cells were treated for 1 h with or without 10 mM SP600125 followed by 820 mg/mL FE for 6 h. Phosphorylated forms of JNK were
determined by western blotting using a specific antibody.
doi:10.1371/journal.pone.0027441.g006
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phosphorylation prevented apoptosis. Furthermore, SP600125
attenuated the loss of DYm, suggesting that phosphorylation of
JNK was partially responsible for the collapse of DYm. These
results suggest that JNK acts as an important mediator of the
pro-apoptotic effects of FE. JNK is likely to phosphorylate and
activate a mitochondrial target in a process directly or indirectly
linked to cell death in FE-treated MCF-7 cells. It is possible that
sustained phosphorylation of JNK perturbs the balance of Bcl-2
family proteins to commit the cell to apoptosis. The fact that
Jnk
-/- MEFs exhibit defects in the release of mitochondrial
cytochrome c is further evidence for a JNK-stimulated apoptosis
pathway [48]. In addition, it has been reported that TNFa-
dependent ROS production causes sustained JNK activation and
cell death [49]. Indeed, a mere transient increase in ROS is
linked to opening of the mitochondrial permeability transition
pore, mitochondrial translocation of Bax and Bad, and
cytochrome c release [33]. Our studies show that FE induced
generation of ROS. The scavenger NAC was found to decrease
the percentage of cells that lose DYm and inhibit apoptotic cell
Figure 7. Effect of ROS on FE-induced apoptosis. (A and B) Cells were pretreated for 1 h with or without 2 mM NAC followed by 820 mg/mL FE
for 15–360 min. The cells were labeled with 5 mM DCFH-DA, and the fluorescence was measured using the IN Cell Analyzer 1000 as explained in the
methods section. (C) Cells were treated with 820 mg/mL FE for 48 h after incubation with 2 mM NAC for 1 h and then the apoptotic cells were
analyzed using the IN Cell Analyzer 1000. (D) MCF-7 cells were treated with 2 mM NAC for 1 h before treatment with 820 mg/mL FE for 6 h.
Phosphorylation of JNK, p38, and ERK1/2 MAPKs was detected by western blotting. (E) Cells were pretreated with 2 mM NAC and 10 mM SP600125 for
1 h and then incubated with 820 mg/mL FE for 48 h. Disruption of DYm was detected by Rh123 staining by using the IN Cell Analyzer 1000. All
results were obtained from 3 independent experiments. Differences with p,0.05(*) or p,0.01(**) are considered statistically significant.
doi:10.1371/journal.pone.0027441.g007
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creased the FE-induced phosphorylation of JNK, p38, and
ERK1/2 in MCF-7 cells, suggesting that an ROS signaling
pathway is related to the phosphorylation of JNK, p38, and
ERK1/2. These results support the hypothesis that the
generation of ROS precedes the phosphorylation of JNK, p38,
and ERK1/2 and that this generation of ROS could cause the
mitochondrial permeability transition.
Cancer cells exhibit increased glycolysis and use this metabolic
pathway to ATP as a main source of their energy supply [50].
Our results showed that ATP depletion occurred in FE-treated
MCF-7 cells and that this ATP depletion preceded changes in
Annexin V-FITC staining. Glucose deprivation is known to
result in depletion of cellular ATP and in turn cause cell death
[51–52]. Moreover, cellular glucose uptake is related to the
sensitivity of the drug [53–55]; the reduction in ATP depletion
might reflect the sensitivity of FE in MCF-7 cells. It is also
possible that the decreased ATP is attributable to the cell death
induced by FE, as plasma membrane damage renders ATP
completely undetectable [56]. Together, these data suggest that
FE impacts intracellular ATP concentration. Future studies
focused on this observation will improve our understanding of
the cellular metabolic signals that induce and effect FE-mediated
cell death.
Fucoidan extract has been used in clinical trials in recent years.
Nishimoto observed rapid increases of interleukin 12, interferon
c, and TNF-a values in the blood of a breast cancer patient (45-
years-old female) after oral administration of 200 mL fucoidan
extract solution (40 mg/kg/day) for 1.5 and 4 months [4]. Two
cervical cancer patients (a 49-year-old female and a 24-year-old
female), a renal cancer patient (81-year-old male), and a liver
cancer patient (74-year-old female) also experienced improve-
ment in their symptoms after receiving fucoidan extract orally at
30–40 mg/kg/day [4]. Since 2004, Takada [57] has performed a
clinical trial in three patients (a 47-year-old female, a 78-year-old
male, and an 84-year-old female) with hepatocellular carcinoma.
The patients who received 180–400 mL of FE orally per day (30–
80 mg/kg/day) showed overall decreases in their a-fetoprotein
(AFP) and des-y-carboxyprothrombin (DCP) levels after several
days’ treatment. The patients experienced significant quality-of-
life improvements during the initial 3–5 months of oral therapy
and subsequent remission or disappearance of their cancers.
Although there is no clearly evident theoretical mechanism to
account for the potentially improved response and survival rates
in carcinoma patients treated with FE, these findings suggest that
FE is safe for cancer patients and has potential for use for cancer
prevention and intervention in humans. Fucoidan extract of an
average molecular weight of 28.8 kDa was detected without
degradation in subjects’ serum, plasma, and urine 6 h after oral
administration [58]. In fact, the average molecular weight of FE
used in our study was about 500 Da, far lower than that of
traditional fucoidan. Sulfated polysaccharides from the same
family may exhibit different properties depending on their
electrical charges, degrees of sulfation, and molecular weights
[1,59–60]. The low molecular weight of FE is expected to
facilitate rapid absorption into blood vessels and effective action
against cancers of various organs.
In conclusion, our study demonstrates that FE inhibits growth
of the MCF-7, MDA-MB-231, HeLa, and HT1080 cell lines.
We present evidence that FE induces a caspase-independent
mitochondria-mediated apoptotic pathway in MCF-7 cells
(Figure 9). FE treatment increases phosphorylation of JNK,
p38, and ERK1/2 kinases and triggers MMP by modulating
expression of Bcl-2 family members and depolarizing mito-
chondrial membranes; these effects may be due in part to
increased levels of ROS. Upstream activation of JNK is a
functionally relevant event that promotes DYm dissipation and
subsequent apoptosis. MMP is followed by the release of
cytochrome c and AIF. AIF translocates into the nucleus and
induces chromatin condensation and DNA fragmentation,
leading to nuclear apoptosis. These findings greatly contribute
to the understanding of the anti-tumor activity of FE.
Combination treatment with FE for cancer is already under
investigation; positive results, if confirmed, would provide
invaluable insight into new approaches to the development of
effective chemotherapy regimens.
Figure 8. Effect of FE on the cellular metabolism. (A) Cells were treated with glucose deprivation, 820 mg/mL FE, or 820 mg/mL FE in
combination with glucose deprivation. The ATP concentration was analyzed with the Bioluminescence assay Kit. Reactions were carried out in
triplicate and ATP concentrations were expressed as percentages of untreated controls. (B) Cells were treated with glucose deprivation, 820 mg/mL
FE, or 820 mg/mL FE in combination with glucose deprivation. Annexin V-PI double staining was used to analyze apoptotic cell death using the IN Cell
Analyzer 1000.
doi:10.1371/journal.pone.0027441.g008
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Materials
The abalone glycosidase-digested fucoidan extract prepared
from seaweed Mozuku of Cladosiphon novae-caledoniae Kylin from the
Kingdom of Tonga, which is commercially available as a product
named ‘‘Power fucoidan’’ and was donated for this study by the
Daiichi Sangyo Corporation (Osaka, Japan).
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bro-
mide (MTT) and propidium iodide (PI) were purchased from
Wako Pure Chemical Industries, Ltd. (Osaka, Japan). The
annexin V-FITC apoptosis kit was obtained from Medical and
Biological Laboratories Co., Ltd. (Nagoya, Japan). Rh123 and -
CellstainH- Hoechst 33342 were obtained from DOJINDO
Laboratories (Kumamoto, Japan). 29,79-Dichlorofluorescin diac-
etate (DCFH-DA) was purchased from Merck KGaA (Darm-
stadt, Germany). The Mitochondrial/Cytosol Fractionation Kit
was obtained from BioVision (San Francisco, CA). MitoTracker
Red CMXRos Mitochondrial Probe was purchased from
Molecular Probes, Inc. (Eugene, OR). The general inhibitor
(Z-VAD-fmk) and the caspase-3/7 inhibitor (Ac-DEVD-CHO)
were purchased from Promega (Madison, WI). The caspase-8
inhibitor (Ac-IETD-CHO) and the caspase-9 inhibitor (Z-
LEHD-fmk) were purchased from BD Biosciences (San Diego,
CA). The JNK inhibitor SP600125 and the p38 inhibitor
SB203580 were purchased from Enzo Life Sciences Internation-
al, Inc. (Plymouth Meeting, PA). Staurosporine (STS) and the
ROS inhibitor NAC were purchased from Sigma-Aldrich Co.
(St. Louis, MO). The ERK inhibitor PD98059 (Merck KGaA)
was used in this study. All of the primary antibodies used in the
study were purchased from Cell Signaling Technology, Inc.
(Danvers, MA). Horseradish peroxidase (HRP)-linked anti-
rabbit/mouse (Cell Signaling Technology) or Alexa-488-labeled
goat anti-rabbit (Invitrogen, Carlsbad, CA) IgG antibodies were
used as secondary antibodies.
Cell culture
The human breast cancer cell lines (MCF-7 and MDA-MB-
231), HeLa cervical carcinoma cell line, HT1080 fibrosarcoma cell
line, and human mammary epithelial cell line (MCF-10A) were
obtained from the American Type Culture Collection (Manassas,
VA). All cell lines except for MCF-10A were maintained in DME
medium (1 mg/mL glucose) supplemented with 10% fetal bovine
serum in an incubator in a humidified atmosphere of 5% CO2,a t
37uC. MCF-10A cells were cultured in mammary epithelial basal
medium (Lonza Group Ltd., Basel, Switzerland). After 24 h, the
medium was replaced with fresh medium containing various
concentrations of FE. Cells grown in a medium containing
phosphate-buffered saline (PBS) without FE served as a control.
Cell proliferation assay
Cell proliferation was analyzed using the MTT assay. Cells were
seeded in 96-well plates at densities of 1000 to 3000 cells/well
(1000 cells/well of malignant cell lines, 3000 cells/well of non-
malignant MCF-10A) and incubated for different time periods
with or without different concentrations of FE. At the required
time point, 10 mL of MTT solution (5 mg/mL) was added to each
well. The plates were incubated for an additional 4 h at 37uC. The
medium was removed and 200 mL DMSO was added to each well
and pipette up and down several times to dissolve the formazan.
The absorbance of each well was measured at 570 nm with a
microplate reader (Tecan Group Ltd., Ma ¨nnedorf, Switzerland).
Flow cytometric analysis
Evaluation of the cell cycle distribution and sub-G1 peaks by
flow cytometric analysis was performed as follows: cells were
collected by trypsin, washed in cold PBS, and fixed with 70%
ethanol on ice for 30 min. After removing the ethanol by washing
with PBS, the cells were incubated in 10 mg/mL RNase A for
30 min at room temperature and then in 20 mg/mL PI for 10 min
in the dark. Cells were then analyzed by flow cytometry (Beckman
Figure 9. A model summarizing the mechanism of FE-induced apoptotic cell death in MCF-7 breast cancer cells.
doi:10.1371/journal.pone.0027441.g009
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4 cells were
recorded.
Apoptosis assay
The annexin V-PI double-staining method was used. MCF-7
cells were seeded onto 96-well plates (5610
3 cells/well) and
cultured for 24 h. After treatment with or without FE for varying
lengths of time, the cells were stained with the annexin V-FITC
labeling solution (annexin V-fluorescein in a binding buffer
containing PI and Hoechst 33342). The plates were further
incubated for 15 min in the dark, and then images of the cells
were acquired using an IN Cell Analyzer 1000 (GE Healthcare
UK Ltd., Buckinghamshire, UK). The cells with apoptotic
morphology of nuclei (condensation/fragmentation) or annexin
V-positive cells were analyzed using the Developer Toolbox
software (GE Healthcare). For each analysis, 3,000 cells were
recorded.
Mitochondrial membrane potential assay
Mitochondrial membrane potential was measured with the IN
Cell Analyzer 1000 using Rh123, PI, and Hoechst 33342 staining.
Disruption of DYm is associated with a lack of Rh123 retention
and a decrease in fluorescence. Briefly, after FE treatment, MCF-7
cells were washed twice with PBS and incubated with 1 mM
Rh123 and 2 mg/mL Hoechst 33342 at 37uC for 30 min. Cells
were then washed twice with PBS, and stained with 10 mg/mL PI
for 5 min. The fluorescence of Rh123 was determined with the IN
Cell Analyzer 1000. For each analysis, 3,000 cells were recorded.
Cells with reduced fluorescence (less Rh123) were identified as
having lost some of their mitochondrial membrane potential.
Image analysis was carried out using IN Cell Investigator software
with either the Developer Toolbox or the Multi-Target Analysis
(MTA) Module (GE Healthcare).
Measurement of intracellular ROS
The intracellular generation of ROS was analyzed with the IN
Cell Analyzer 1000. After incubation of FE for the indicated times,
MCF-7 cells were incubated with 5 mM DCFH-DA at 37uC for
30 min. Then, the cells were washed twice with PBS and stained
with 2 mg/mL Hoechst 33342 at 37uC for 15 min. The cellular
fluorescence intensity was measured with the IN Cell Analyzer
1000 after washing the cells twice with PBS. For each sample,
3,000 events were recorded. Image analysis was carried out using
the IN Cell Investigator software, using either the Developer
Toolbox or the Multi-Target Analysis (MTA) Module (GE
Healthcare).
Immunofluorescence
AIF translocation from the mitochondria to the nuclei was
analyzed by immunofluorescence. Briefly, cells were incubated
with different concentrations of FE. Then, the cells were
incubated with the mitochondrial dye MitoTracker Red
CMXRos at 200 nM for 30 min, washed with PBS twice, and
fixed with 3.7% formaldehyde in PBS for 15 min. After rinsing
several times with PBS, the cells were permeabilized with 0.1%
Triton X-100 in PBS at room temperature for 10 min. Cells were
then blocked with 0.1% BSA at room temperature for 1 h and
subsequently incubated with a primary AIF antibody (1:200)
overnight at 4uC and an Alexa-488-labeled anti-rabbit IgG
antibody (1:250) for 1 h at room temperature. Nuclei were
stained with Hoechst 33342 for 15 min after secondary antibody
incubation. Images were then captured with the IN Cell Analyzer
1000 (GE Healthcare) with 475/535 nm excitation/emission
filters.
Western blot analysis
Cells were washed twice with cold PBS and lysed with lysis
buffer (50 mM Tris-HCl, 150 mM NaCl, 2 mM EDTA, 10%
Nonidet P-40, 50 mM NaF, 1 mM Na3VO4,a n dp r o t e a s e
inhibitor cocktail) for 20 min on ice. Protein extracts were
centrifuged at 17,530 6g for 10 min at 4uC. Mitochondria and
cytosolic fractions were separated using the Mitochondria/
Cytosol fractionation kit according to the manufacturer’s
protocol (BioVision). The protein concentration was determined
using the Bradford Protein Assay Reagent. Equal amounts of
protein from each sample were separated by electrophoresis
through SDS-PAGE gels and transferred to PVDF membranes
(GE Healthcare). Membranes were blocked for 1 h at room
temperature in Tris-buffered saline containing 0.1% Tween-20
and 5% nonfat dry milk. The membrane was incubated
overnight at 4uC with the primary antibody diluted in 5%
nonfat dry milk or 5% BSA. The membranes were washed 3
times and incubated for 1 h at room temperature with the HRP-
conjugated secondary antibody. Protein bands were visualized
using enhanced chemiluminescence as described by the supplier
(GE Healthcare).
Cell transfection
MCF-7 cells were seeded at 2610
5 cells per well in 6-well plates
24 h before transfection. Transfection was performed using
HilyMax (Dojindo, Kumamoto, Japan) according to the manu-
facturer’s protocol. The MCF-7/Bcl-2 cell line overexpressing Bcl-
2 was established by transfecting MCF-7 cells with the pCMV-Bcl-
2 plasmid encoding human Bcl-2 cDNA followed by selection with
1 mg/mL G418 for two weeks. G418-resistant clones were pooled
for further experiments. MCF-7 cells transfected with an empty
pRc/CMV vector (MCF-7/vec) were used as controls.
ATP concentration Assay
The ATP concentration was measured by the Bioluminescence
assay Kit CLS II (Roche Diagnostics Co., Indianapolis, IN)
according to the manufacturer’s instructions. In brief, untreated or
treated MCF-7 cells were collected in minimal volumes and mixed
with 9 volumes of boiling 100 mM Tris, 4 mM EDTA (pH 7.75).
The samples were incubated for another 2 min at 100uC and
centrifuged at 1000 6g for 60 s. The ATP concentration was then
measured with a luminometer (Berthold Technologies) against an
ATP standard curve. Reactions were carried out in triplicate and
ATP concentrations were expressed as percentages of untreated
controls.
Statistical analysis
All experiments were performed at least in triplicate. Data are
presented as mean 6 S.D., and p values were analyzed using the
Student’s t-test accompanied by analysis of variance (ANOVA)
where appropriate.
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